Purchases and Sales Made in Q2 2025 in Foghorn Therapeutics Inc. (FHTX)
This table provides information about the institutional ownership of Foghorn Therapeutics Inc. (FHTX) during Q2 2025. The information is specifically focused on institutions that hold shares of Foghorn Therapeutics Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2025
Q2 2025
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-4.3K- 1.41% |
$13.5K - $21.1K
|
300K
$1.46M
|
|
Aug 11, 2025
Q2 2025
|
Citigroup Inc
|
SELL
|
- |
-6.17K- 32.78% |
$19.4K - $30.2K
|
12.7K
$61.7K
|
|
Aug 12, 2025
Q2 2025
|
Nuveen, LLC
Charlotte, NC |
SELL
|
- |
-10.3K- 17.05% |
$32.5K - $50.5K
|
50.1K
$244K
|
|
Aug 14, 2025
Q2 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-21.4K- 38.04% |
$67.5K - $105K
|
34.9K
$170K
|
|
Aug 14, 2025
Q2 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-42.6K- 7.26% |
$134K - $209K
|
544K
$2.65M
|
|
Aug 14, 2025
Q2 2025
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-49.2K- 20.33% |
$155K - $241K
|
193K
$938K
|